Literature DB >> 10380061

Treatment of prostate cancer.

R Y Henry1, D O'Mahony.   

Abstract

Prostate cancer is the leading cause of cancer death among older men in western countries. However, controversy surrounds many issues related to this disease, particularly its most appropriate treatment, with a wide spectrum of opinions ranging from watchful waiting to aggressive therapy. Patients with newly diagnosed prostate cancer, as well as their doctors, will have to make difficult decisions regarding treatment of this disease. In this article we discuss the current available treatment options and some novel therapeutic approaches to tackling the patient with prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380061     DOI: 10.1046/j.1365-2710.1999.00207.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  4 in total

Review 1.  Age differences in dual information-processing modes: implications for cancer decision making.

Authors:  Ellen Peters; Michael A Diefenbach; Thomas M Hess; Daniel Västfjäll
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

2.  Identification of candidate genes that may contribute to the metastasis of prostate cancer by bioinformatics analysis.

Authors:  Lingyun Liu; Kaimin Guo; Zuowen Liang; Fubiao Li; Hongliang Wang
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

3.  Preoperative factors predictive of continence recovery after radical retropubic prostatectomy.

Authors:  Tae Joon Lim; Jee Han Lee; Joo Won Lim; Sung Kyoung Moon; Seung Hyun Jeon; Sung-Goo Chang
Journal:  Korean J Urol       Date:  2012-08-16

4.  Bio-Catalytic Structural Transformation of Anti-cancer Steroid, Drostanolone Enanthate with Cephalosporium aphidicola and Fusarium lini, and Cytotoxic Potential Evaluation of Its Metabolites against Certain Cancer Cell Lines.

Authors:  M Iqbal Choudhary; Mahwish Siddiqui; Sammer Yousuf; Narjis Fatima; Malik S Ahmad; Hani Choudhry
Journal:  Front Pharmacol       Date:  2017-12-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.